Cytrx Corp (NASDAQ:CYTR)

CAPS Rating: 2 out of 5

A biopharmaceutical research and development company engaged in developing human therapeutic products based primarily upon its small molecule molecular chaperone co-induction technology.

Recs

0
Player Avatar TheSwoonie (24.47) Submitted: 12/22/2007 10:29:40 AM : Outperform Start Price: $18.04 CYTR Score: -73.39

Good platform of trials, take over target.

Featured Broker Partners


Advertisement